[{"id":"9507ed2f-0466-4ed9-9e93-1955c7856ffd","acronym":"","url":"https://clinicaltrials.gov/study/NCT05065710","created_at":"2021-10-04T12:52:58.772Z","updated_at":"2024-07-02T16:35:01.207Z","phase":"Phase 1/2","brief_title":"A Study of ZL-1211 in Patients With Advanced Solid Tumor","source_id_and_acronym":"NCT05065710","lead_sponsor":"Zai Biopharmaceutical (Suzhou) Co., Ltd.","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ZL-1211"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 01/19/2022","start_date":" 01/19/2022","primary_txt":" Primary completion: 03/09/2024","primary_completion_date":" 03/09/2024","study_txt":" Completion: 04/09/2024","study_completion_date":" 04/09/2024","last_update_posted":"2024-05-24"}]